BioCentury
ARTICLE | Company News

Array BioPharma, Asahi Kasei Pharma deal

April 18, 2016 7:00 AM UTC

Array granted Asahi exclusive rights in Japan, Korea, Taiwan and China to commercialize and develop ARRY-954 and other select neurotrophic tyrosine kinase receptor 1 ( TrkA; NTRK1) inhibitors to tr...